TITLE

Myocarditis and Hepatitis B Virus

AUTHOR(S)
Mahapatra, Rajat K.; Ellis, Gregory H.
PUB. DATE
February 1985
SOURCE
Angiology;Feb1985, Vol. 36 Issue 2, p116
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Two patients with hepatitis B virus infection and myocarditis are reported. The implicated pathogenesis was an immune complex mechanism in one patient. Both patients presented with heart failure and arrythmia which were controlled with conventional medical therapy. Echocardiography played an important role for early detection of left ventricular dysfunction. The efficacy and safety of corticosteroid therapy is still conjectural. Acute hepatitis B infection should be a differential diagnostic consideration in the etiology of acute myocarditis.
ACCESSION #
16365521

 

Related Articles

  • Response to Lamivudine Treatment in Children with Chronic Hepatitis B Virus Infection. Hagmann, Stefan; Chung, May; Rochford, Gemma; Jani, Mudra; Trinh-Shevrin, Chau; Sitnitskaya, Yekaterina; Neumann, Avidan U.; Pollack, Henry // Clinical Infectious Diseases;12/1/2003, Vol. 37 Issue 11, p1434 

    Despite the recent approval of lamivudine for the treatment of children with chronic hepatitis B virus (HBV) infection, there is insufficient information on the kinetics of HBV clearance and the factors that predict a favorable treatment response to lamivudine in this population. In a small...

  • Antiretroviral Therapy for Hepatitis B Virus--HIV--Coinfected Patients: Promises and Pitfalls. Levy, Vivian; Grant, Robert M. // Clinical Infectious Diseases;10/1/2006, Vol. 43 Issue 7, p904 

    Coinfections with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) are common globally. HIV infection modifies the course of HBV infection by increasing rates of chronicity, prolonging HBV viremia, and increasing liver-related morbidity. To minimize the emergence of HIV and/or HBV...

  • Hepatitis B Virus Genotype and DNA Level in HCC.  // JNCI: Journal of the National Cancer Institute;2/16/2005, Vol. 97 Issue 4, p241 

    Reports on the findings that chronic hepatitis B virus (HBV) infection is a cause of hepatocellular carcinoma (HCC). Methods used to determine the role of HCC in HBV; Results that suggest measurements of HBV load and genotype may help to define which male HBV carriers are at high risk for HCC;...

  • Hepatitis B Virus DNA Integration in Hepatocellular Carcinoma After Interferon-Induced Disappearance of Hepatitis C Virus. Tamori, Akihiro; Nishiguchi, Shuhei; Shiomi, Susumu; Hayashi, Takehiro; Kobayashi, Sawako; Habu, Daiki; Takeda, Tadashi; Seki, Shuichi; Hirohashi, Kazuhiro; Tanaka, Hiromu; Kubo, Shoji // American Journal of Gastroenterology;Aug2005, Vol. 100 Issue 8, p1748 

    OBJECTIVES: Hepatocellular carcinoma (HCC) has been reported in patients in whom hepatitis C virus (HCV) was eliminated by interferon (IFN) therapy. We examined the pathogenesis of HCC in patients with sustained viral response. METHODS: Operable HCC developed in 7 of 342 patients cured of HCV...

  • Expressed Anti-HBV Primary MicroRNA Shuttles Inhibit Viral Replication Efficiently In Vitro and In Vivo. Ely, Abdullah; Naidoo, Tanusha; Mufamadi, Steven; Crowther, Carol; Arbuthnot, Patrick // Molecular Therapy;Jun2008, Vol. 16 Issue 6, p1105 

    The use of RNA interference (RNAi) to inhibit gene expression is potentially applicable in the treatment of viral infections such as hepatitis B virus (HBV) persistence. Although efficient HBV gene silencing by short hairpin RNA (shRNA) expressed from RNA polymerase (Pol) III promoters has been...

  • Mortality Secondary to Fulminant Hepatic Failure in Patients with Prior Resolution of Hepatitis B Virus Infection in Japan. Umemura, Takeji; Tanaka, Eiji; Kiyosawa, Kendo; Kumada, Hiromitsu // Clinical Infectious Diseases;9/1/2008, Vol. 47 Issue 5, pe52 

    Hepatitis B virus (HBV) reactivation in patients with resolved HBV infection was found in 23 (4%) of 552 newly hepatitis B surface antigen-positive patients in Japan. Because onefourth of cases develop into fulminant hepatic failure and mortality is 100%, management of HBV reactivation in...

  • Anti-HBV Drugs: Progress, Unmet Needs, and New Hope. Lei Kang; Jiaqian Pan; Jiaofen Wu; Jiali Hu; Qian Sun; Jing Tang // Viruses (1999-4915);2015, Vol. 7 Issue 9, p4960 

    Approximately 240 million people worldwide are chronically infected with hepatitis B virus (HBV), which represents a significant challenge to public health. The current goal in treating chronic HBV infection is to block progression of HBV-related liver injury and inflammation to end-stage liver...

  • Persistence of the Recombinant Genomes of Woodchuck Hepatitis Virus in the Mouse Model. Pan, Danzhen; Lin, Yong; Wu, Weimin; Song, Jingjiao; Zhang, Ejuan; Wu, Chunchen; Chen, Xinwen; Hu, Kanghong; Yang, Dongliang; Xu, Yang; Lu, Mengji // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Hydrodynamic injection (HI) with a replication competent hepatitis B virus (HBV) genome may lead to transient or prolonged HBV replication in mice. However, the prolonged HBV persistence after HI depends on the specific backbone of the vector carrying HBV genome and the genetic background of the...

  • Widespread hepatitis B virus genotype G (HBV-G) infection during the early years of the HIV epidemic in the Netherlands among men who have sex with men. Cornelissen, Marion; Zorgdrager, Fokla; Bruisten, Sylvia M.; Bakker, Margreet; Berkhout, Ben; van der Kuyl, Antoinette C. // BMC Infectious Diseases;6/10/2016, Vol. 16, p1 

    Background: Hepatitis B virus (HBV) variants belong to different genotypes, A-J, whose worldwide distribution is linked with geography, probably because viral spread was associated with ancient human migrations. HBV genotype G (HBV-G) is an aberrant genotype with little sequence...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics